Villaren, Yanisahara A.

HRN: 28-86-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CEFUROXIME 1.5GM (VIAL)
04/17/2026
04/19/2026
IVTT
1.5g
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: